US Doctors Reconsider Pfizer's Paxlovid for Lower-Risk COVID Patients
Use of Pfizer's COVID-19 antiviral Paxlovid spiked last week, but some doctors are reconsidering the pills for lower-risk patients after a US public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.